Abstract
Summary
Fracture probabilities derived from the original FRAX model for Brazil were compared to those from an updated model based on more recent regional estimates of the incidence of hip fracture. Fracture probabilities were consistently lower in the updated FRAX model. Despite large differences between models, differences in the rank order of fracture probabilities were minimal.
Objective
Recent epidemiological data indicate that the risk of hip fracture in Brazil is lower than that used to create the original FRAX model. This paper describes the epidemiology of hip fracture in Brazil and the synthesis of an updated FRAX model with the aim of comparing this new model with the original model.
Methods
Hip fracture rates from three cities in three regions were combined, weighted by the population of each region. For other major fractures, incidence rates for Brazil were estimated using Swedish ratios for hip to other major osteoporotic fracture (humerus, forearm or clinical vertebral fractures). Mortality estimates were taken from the UN.
Results
Compared to the original FRAX model, the updated model gave lower 10-year fracture probabilities in men and women at all ages. Notwithstanding, there was a very close correlation in fracture probabilities between the original and updated models (r > 0.99) so that the revisions had little impact on the rank order of risk.
Conclusion
The disparities between the original and updated FRAX models indicate the importance of updating country-specific FRAX models with the advent of significant changes in fracture epidemiology.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
FRAX® is a computer-based algorithm (http://www.shef.ac.uk/FRAX) developed by the then World Health Organization Collaborating Centre for Metabolic Bone Diseases and first released in 2008. The algorithm, intended primarily for use in primary care, calculates fracture probability from easily obtained clinical risk factors (CRFs) in men and women [1, 2]. The output of FRAX is the 10-year probability of a major fracture (hip, clinical spine, humerus or wrist fracture) and the 10-year probability of hip fracture. Probability is calculated from the risk of fracture and death according to age, body mass index (BMI) and dichotomized risk factors comprising prior fragility fracture, parental history of hip fracture, current tobacco smoking, long-term oral glucocorticoid use, rheumatoid arthritis, other causes of secondary osteoporosis and excessive alcohol consumption. Femoral neck bone mineral density (BMD) can be optionally input to enhance fracture risk prediction [3].
The risk of hip fracture and probably of other osteoporotic fractures varies markedly around the world. In addition, the age-specific risk of death varies between countries. This variation also contributes to the heterogeneity in fracture probability [4]. For this reason, FRAX models are calibrated to those countries where the epidemiology of fracture and death is known. Models are currently available for 81 countries or territories covering more than 80% of the world population age 50 years or more [5].
A FRAX model for Brazil was released on May 1, 2013 (http://www.shef.ac.uk/FRAX). FRAX Brazil relied on data now more than 20 years old [6]. Age- and sex-stratified hip fracture incidence rates were extracted from four regional estimates from the age of 40 years [7,8,9,10]. The estimates were from Porto Allegre, Marilia, Sobral and Fortaleza. For other major fractures, incidence rates for Brazil were estimated using Swedish ratios for hip to other major osteoporotic fracture (humerus, forearm or clinical vertebral fractures). Since then, several more recent studies on the epidemiology of fractures have been published [11, 12] including the Brazilian Validation Osteoporosis Study (BRAVOS), specifically conducted to update FRAX [13]. These more recent publications indicate that hip fracture incidence in recent years is substantially lower than that used for the original version of FRAX.
The aim of the present study was to provide an update of the FRAX model for Brazil using the data from the BRAVOS study and to compare probabilities with the original FRAX model.
Methods
The BRAVOS study documented the incidence of hip fracture in three representative Brazilian cities, Belem (in the Northeast region) Vitoria (Southeast) and Joinville (South). Details have been previously published [13]. In brief, this was a retrospective, observational study including all patients aged ≥ 50 years admitted in hospitals because of a hip fracture from 2010 to 2012. Data were obtained from medical records. Fractures (ICD-10 codes S72.0, S72.1, S72.2) were extracted by trained personnel and a central review process was established to confirm the diagnosis of hip fractures and the completeness and accuracy of the data. If the patient sustained a contralateral hip fracture during the survey, it was registered as a new fracture. Annual incidence of hip fracture was determined in men and in women in 5-year age intervals rates. Age-standardised hip fracture rates were lowest in Belem, intermediate in Vitoria and highest in Joinville. The hip fracture incidence in Belem was significantly lower than that in Vitoria and Joinville.
Brazil is divided in five regions, but the majority of the population lives in the Southeast (42%), Northeast (28%) and South (14%). In order to create a single FRAX model, hip fracture rates of the three cities from these regions were combined weighted by the population of each region. This assumes that the hip fracture incidence in each city was representative of each region. The point estimates of incidence at each age interval were log-transformed and, since the data followed different linear trends over different ages, piecewise linear regression was used to more accurately summarise the relationship between age and log incidence. Breakpoints for the regression were at 62 and 87 years of age for men and 62 and 82 years for women. The estimated number of hip fractures in men and women nationwide was calculated from the age of 50 years from population demography [14]. The incidence of other major osteoporotic fractures (clinical spine, distal forearm and proximal humerus) could not be determined from literature sources. It was assumed, therefore, that these age- and gender-specific ratios found in Sweden were comparable to those in Brazil. This assumption has also been used for many of the FRAX models with incomplete epidemiological information. Available information suggests that the age- and gender-stratified pattern of fracture is very similar in the Western world and Australia [15,16,17,18,19].
The development and validation of FRAX has been extensively described [1, 2]. The risk factors used were based on a systematic set of meta-analyses of population-based cohorts worldwide and validated in independent cohorts with over a million patient-years of follow-up. The construct of the FRAX model for Brazil required the beta coefficients of the risk factors in the original FRAX model and the incidence rates of hip fracture and mortality rates for Brazil [6]. The relative importance of the beta coefficients for death and fracture was assumed to be similar in Brazil, as has been shown across many countries [2]. However, absolute age-specific fracture risk and mortality rates differ from country to country [4]. Consequently, for each age category, the hazard function was calibrated to match the mean risk (both fracture risk and mortality rate) for that specific age group in Brazil, without altering the relative importance of the beta coefficients. National mortality rates used data for 2015–2019 available from the United Nations [20].
Comparison of models
For the purpose of comparing the new FRAX model and the original model, the probabilities of a major osteoporotic fracture (hip, clinical spine, forearm and humeral fractures) and of hip fracture alone were computed in men and women at ages 50, 60, 70 and 80 years for all possible combinations of clinical risk factors at BMD T-scores between 0 and − 3.5 SD in 0.5 SD steps with a BMI set to 25 kg/m2 [19, 21]. Thus, we considered all combinations of six risk factors and eight values of BMD giving a total number of combinations of 512 for each age. The probabilities were calculated with the FRAX desktop multi-patient entry tool (FRAX Desktop (frax-tool.org)). Note that this was not a population simulation, but an array of all possible combinations. The relationship between probabilities of the original and the updated FRAX model followed different linear trends over different probability estimates so that piecewise linear regression was used to more accurately summarise the relationship between the FRAX models. The correlation between the probabilities derived from the original and updated models used a breakpoint at 30% for the probabilities of a major osteoporotic fracture and hip fracture. Tabular data were used to compare probabilities between the two versions at the 50th (median) percentile of the distribution of the surrogate model. Differences in the authentic model from the surrogate model at these percentiles were expressed as 95% tolerance intervals (TI).
Results
The incidence of hip fractures increased exponentially with age and women had a risk about 50% higher than that of men from the age of 70 years (Fig. 1). Hip fracture rates were approximately half of than those used in the original FRAX model. The number of hip fractures nationally in 2021 was estimated at 56,526, of which 19,555 (35%) were in men and 36,971 in women.
The relationship between the probabilities of a hip fracture derived from all permutations of risk factor and age combinations in the two versions of FRAX is shown for women age 50 to 80 years in Fig. 2. At all ages, there was a close correlation between the two estimates (r > 0.99). The update version gave consistently lower probabilities than the original model at all ages. The effect in men was very similar to that of women.
Table 1 provides median values for the 10-year probability of hip fracture and MOF for the original and update FRAX model. The median value for hip fracture probability was lower by 26–44% in both men and women depending on age. In the case of MOF, there was also a close correlation between the two estimates (r > 0.99) at all ages. The update version gave lower estimates for MOF probability than the original model by 20–56% in both men and women depending on age.
Examples of fracture probabilities with the original and updated model in a woman with a prior fracture and a body mass index of 25kg/m2 is shown in Fig. 3.
Discussion
In this study, we used recent data on the incidence of hip fracture in Brazil to update the original FRAX model [6]. In brief, the revision provided lower estimates of fracture probability at all ages than the original model. Importantly, the update had little impact on the categorisation of risk, since the rank order of fracture probability did not change. In the clinical scenarios presented in this paper, the correlation coefficients between the original and revised versions for fracture probability exceeded 0.99, so that the one can be accurately predicted from the other. In other words, an individual at the 90th percentile of risk would still be at the 90th percentile of risk using the updated FRAX tool. Thus, the consequences of improving accuracy reside in the absolute number generated and not in the rank order of risk within a population. Similar close correlations between original and revised FRAX models have been reported for the USA, Armenia and Ecuador [19, 21, 22]. Because of the close correlation, the difference in probabilities is of little consequence to the management of patients. There is a useful analogy with the different DXA devices available, where a substantial difference in femoral neck BMD is seen between Hologic and Lunar machines, but the T-score derived from these is more or less identical [23]. However, marked difficulties arise when fracture probabilities are used in health economic analysis to inform practice guidelines or to set probability-based intervention thresholds. In this context, accuracy is mandatory.
The principal reason that the revised model gave lower fracture probabilities than the original model for Brazil lay in the lower incidence of hip fracture in the BRAVOS study. That hip fracture risk is lower than that utilised for the original model is consistent with other more recent data. Thus, a similarly low incidence was determined from a retrospective analysis of the Brazilian Public Health System [12]. Additionally, a national survey in 2017 estimated 47,974 hip fractures in patients covered by the Public Health System [11]. If this is uplifted by 25% (to account for the private sector [24]), the number of hip fractures in Brazil (59,966) is markedly less than that estimated from data used to build the original FRAX model (80,640 for 2015) [6] but consistent with the present study (56,526). A comparison of probabilities of the updated model with the original model is given in Table 2 for men and women age 65 years with a prior fragility fracture together with other Latin American countries where a FRAX model is available. The probabilities of the updated model lay within the range observed in Latin America though the revision ranked somewhat lower.
The BRAVOS study, on which the present report is based [13], confirms that there are large regional differences in the incidence of hip fracture in Brazil [11, 12]. Lowest rates are reported in the North and Northeast regions with progressively higher rates in the Centralwest, South and Southeast regions, respectively [12]. Regional differences of similar magnitude are reported elsewhere, and fracture rates are generally higher in urban communities than in rural communities as shown in Argentina [25], Croatia [26], Norway [27,28,29], Sweden [30, 31], Switzerland [32], Turkey [33] and in the USA [34, 35]. Reasons for these differences are conjectural but include differences in vitamin D status, everyday level of physical activity, factors related to socioeconomic prosperity and racial admixture [13, 31, 36, 37].
The regional differences have led to the view that more than one FRAX model is required for Brazil [12] as is available for the USA [38], Singapore [39], Malaysia [40] and South Africa [41]. The principal reason for the development of a single rather than regional model is the difficulty in the practical application of several regional models with uncertain boundaries. Moreover, the heterogeneity in incidence may be explained in part by differences in ethnic mix. There are, however, no studies available that characterise fracture risk by ethnicity in Brazil, though lower fracture rates are well established in blacks compared with whites in the USA and South Africa [41, 42]. Belem has a predominance of brown and blacks (72%), compared to whites (28%) whereas in Vitoria the prevalence ratio is 59% vs. 42%, respectively [13]. Assuming that race/ethnicity explains the difference in incidence between Belem and Vitoria then the incidence in Joinville (ratio 17% vs. 84%) would be 241/100,000 rather than the observed rate of 94/100,000. This suggests that race is unlikely to explain the totality of regional differences. Notwithstanding, future studies on the epidemiology of fracture would benefit by the characterisation of race.
The present study has several limitations. The data on hip fracture rates are based on regional rather than national estimates and are not necessarily representative of the whole country. The assumption is made that the cities reflect the regional epidemiology and that the three regions are representative of Brazil. Interestingly, the weighted ethnicity would approximate that of Brazil (White 49.3%, Brown 45% and Black 6.9%). Additionally, the reporting of conservative management or non-admission rates to hospital may have differed between regions introducing an unquantifiable bias. As noted above, not only may fracture rates differ according to ethnicity but so do death rates [43] that would in turn affect fracture probabilities. We also assumed that age- and sex-specific ratios of major osteoporotic fracture to hip fracture in different ethnic groups in Brazil were comparable, an assumption that could not be tested. In addition, the relative importance of the beta coefficients for death and fracture was assumed to be similar in Brazil as in the populations used to create and validate FRAX [44].
We conclude that age- and sex-specific hip fracture rates are significantly lower than previously reported in Brazil. A revision of the FRAX model for Brazil provides lower fracture probabilities than those derived from the original FRAX model for Brazil. Despite large differences between models, differences in the rank order of fracture probabilities were minimal.
References
Kanis JA on behalf of the World Health Organization Scientific Group (2007a) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. Accessible at http://www.shef.ac.uk/FRAX. Accessed 26th February 2023
Kanis JA, Johnell O, Oden A, Johansson H, McCloskey EV (2008) FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046
Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl D, Cyrus Cooper C on behalf of the IOF Working Group on Epidemiology and Quality of Life (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–2256
Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV and the Epidemiology and Quality of Life Working Group of IOF (2013) Worldwide uptake of FRAX. Arch Osteoporos 9:166. https://doi.org/10.1007/s11657-013-0166-8
Zerbini CAF, Szejnfeld VL, Abergaria BH, McCloskey EV, Johansson H, Kanis JA (2015) Incidence of hip fracture in Brazil and the development of a FRAX model. Arch Osteoporos 10:224. https://doi.org/10.1007/s11657-015-0224-5
Komatsu RS, Ramos LR, Szejnfeld VL (2004) Incidence of proximal femur fractures in Marilia, Brazil. J Nutr Health Aging 8:362–367
Silveira VA, Medeiros MM, Coelho-Filho JM, Mota RS, Noleto JC, Costa FS, Pontes FJ, Sobral JB, Aguiar RF, Leal AC, Clemente CM (2005) Incidência de fratura do quadril em área urbana do Nordeste brasileir;o [Hip fracture incidence in an urban area in Northeast Brazil]. Cad Saude Publica 21:907–912
Schwartz AV, Kelsey JL, Maggi S, Tuttleman M, Ho SC, Jónsson PV, Poór G (1999) Sisson de Castro JA, Xu L, Matkin CC, Nelson LM, Heyse SP (1999) International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on Aging. Osteoporos Int 9:242–253
Castro da Rocha FA, Ribeiro AR (2013) Low incidence of hip fractures in an equatorial area. Osteoporos Int 14:496–499
Stolnicki B, Teixeira BC (2020) The impact of hip fractures in the public health system in Brazil (SUS) 2008–2017: the orthopedist task. Rev Bras Ortop (Sao Paulo) 57:552–559. https://doi.org/10.1055/s-0040-1713762
da Silva ARB, Martinez LC, de Medeiros PM, Szejnfeld VL (2022) Secular trends in hip fractures in adults over 50 years old: a retrospective analysis of hospital admissions to the Brazilian Public Health System from 2004 to 2013. Arch Osteoporos 17:50. https://doi.org/10.1007/s11657-022-01092-y
Albergaria BH, Zerbini CAF, Szejnfeld VL, Eis SR, Silva DMW, de Fatima Lobato da Cunha M, McClung MR, Kanis JA, McCloskey EV, Vilaca T, Lazaretti-Castro M (2022) An updated hip fracture incidence rate for Brazil: the Brazilian Validation Osteoporosis Study (BRAVOS). Arch Osteoporos. 2(17):90. https://doi.org/10.1007/s11657-022-01127-4
Instituto Brasileiro de Geografia e Estatística (2021) Population Estimates https://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2021/estimativa_dou_2021.pdf Accessed 20 March 2023
Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11:669–674
Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV, Task Force of the FRAX Initiative (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:2395–411
Siggeirsdottir K, Aspelund T, Johansson H, Gudmundsson EF, Mogensen B, Jonsson BY, Gudnason V, McCloskey E, Oden A, Sigurdsson G, Kanis JA (2014) The incidence of a first major osteoporotic fracture in Iceland and implications for FRAX. Osteoporos Int 25:2445–2451
Lam A, Leslie WD, Lix LM, Yogendran M, Morin SN, Majumdar SR (2014) Major osteoporotic to hip fracture ratios in Canadian men and women with Swedish comparisons: a population-based analysis. J Bone Miner Res 29:1067–1073
Lesnyak O, Sahakyan S, Zakroyeva A, Bilezikian JP, Hutchings N, Galstyan R, Lebedev A, Johansson H, Harvey NC, McCloskey E, Kanis JA (2017) Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate. Arch Osteoporos 12:98. https://doi.org/10.1007/s11657-017-0392-6
United Nations (2019) Department of Economic and Social Affairs. Population Division. World Population Prospects 2019. Online Edition. Rev.1. https://population.un.org/wpp/
Kanis JA, Johansson H, Oden A, Dawson-Hughes B, Melton LJ 3rd, McCloskey EV (2010) The effects of a FRAX((R)) revision for the USA. Osteoporos Int 21:35–40
Lopez Gavilanez E, Johansson H, McCloskey E, Harvey NC, SegaleBajana A, Marriott Blum D, Navarro Grijalva M, Diaz Curiel M, Kanis JA (2019) Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model. Arch Osteoporos 14:93. https://doi.org/10.1007/s11657-019-0644-8
Binkley N, Kiebzak GM, Lewiecki EM, Krueger D, Gangnon RE, Miller PD, Shepherd JA, Drezner MK (2005) Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. J Bone Miner Res 20:195–201
Agência Nacional de Saúde Suplementar (ANS) (2019) Beneficiários de planos privados de saúde, por cobertura assistencial (Brasil –2009–2019). https://www.gov.br/ans/pt-br/acesso-a-informacao/perfil-do-setor/dados-gerais. Accessed 12 Jine 2023
Wittich A, Bagur A, Mautalen C, Cristofari A, Escobar O, Carrizo G, Oliveri B (2010) Epidemiology of hip fracture in Tucuman. Argentina Osteoporos Int 21:1803–1807
Matkovic V, Kostial K, Simonovic I, Buzina R, Brodarec A, Nordin BE (1979) Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr 32:540–549
Finsen V, Benum P (1987) Changing incidence of hip fractures in rural and urban areas of central Norway. Clin Orthop Relat Res 218:104–110
Bulajic-Kopjar M, Wiik J, Nordhagen R (1998) Regional differences in the incidence of femoral neck fractures in Norway. Tidsskr Nor Laegeforen 118(1):30–3
Kaastad TS, Meyer HE, Falch JA (1998) Incidence of hip fracture in Oslo, Norway: differences within the city. Bone 22:175–178
Jonsson B, Gardsell P, Johnell O, Redlund-Johnell I, Sernbo I (1992) Differences in fracture pattern between an urban and a rural population: a comparative population-based study in southern Sweden. Osteoporos Int 2:269–273
Odén A, Kanis JA, McCloskey EV, Johansson H (2014) The effect of latitude on the risk and seasonal variation in hip fracture in Sweden. J Bone Miner Res 29:2217–2223
Chevalley T, Herrmann FR, Delmi M, Stern R, Hoffmeyer P, Rapin CH, Rizzoli R (2002) Evaluation of the age-adjusted incidence of hip fractures between urban and rural areas: the difference is not related to the prevalence of institutions for the elderly. Osteoporos Int 13(2):113–118
Elffors L, Allander E, Kanis JA, Gullberg B, Johnell O, Dequeker J, Dilzen G, Gennari C, Lopez-Vaz AA, Lyritis G, Mazzuoli GF, Miravet L, Passeri M, Perez Cano R, Rapado A, Ribot C (1994) The variable incidence of hip fracture in southern Europe: the MEDOS Study. Osteoporos Int 4:253–263
Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA (1990) Regional variation in the incidence of hip fracture. US white women aged 65 years and older. JAMA 264:500–502
Madhok R, Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Lewallen DG (1993) Urban vs rural increase in hip fracture incidence. Age and sex of 901 cases 1980–89 in Olmsted County, U.S.A. Acta Orthop Scand 64:543–548
Johnell O, Borgstrom F, Jonsson B, Kanis J (2007) Latitude, socioeconomic prosperity, mobile phones and hip fracture risk. Osteoporos Int 18:333–337
Grant WB (2012) Variations in solar UVB doses and serum 25-hydroxyvitamin D concentrations may explain the worldwide variation in hip fracture incidence. Osteoporos Int. 23:399–400 (author reply 401‐2)
Looker AC, SarafraziIsfahani N, Fan B, Shepherd JA (2017) FRAX-based estimates of 10-year probability of hip and major osteoporotic fracture among adults aged 40 and over: United States, 2013 and 2014. Natl Health Stat Report 103:1–16
Kanis JA, Chandran M, Chionh SB, Ganeson G, Harvey NC, Koh WP, Kwok T, Lau TC, Liu E, Lorentzon M, McCloskey EV, Tan KB, Vandenput L, Johansson H (2020) Use of age-dependent FRAX-based intervention thresholds for Singapore. Arch Osteoporos 15(1):104. https://doi.org/10.1007/s11657-020-00782-9
Johansson H, Chan SP, Hew FL, Yeap SS, Siri Z, Liu E, Lorentzon M, Vandenput L, Harvey NC, McCloskey E, Kanis JA (2022) A surrogate FRAX model for Malaysia. Aging Clinl Exp Res 34(Suppl 1):S250-251
Dela SS, Paruk F, Brown SL, Lukhele M, Kalla AA, Jordaan JD, Conradie M, Mohamed O, Chutterpaul P, Cassim B (2020) Ethnic and gender-specific incidence rates for hip fractures in South Africa: a multi-centre study. Bone 133:115253. https://doi.org/10.1016/j.bone.2020.115253
Cauley JA, El-Hajj Fuleihan G, Arabi A, Fujiwara S, Ragi-Eis S, Calderon A, Chionh SB, Chen Z, Curtis JR, Danielson ME, Hanley DA, Kroger H, Kung AW, Lesnyak O, Nieves J, Pluskiewicz W, El Rassi R, Silverman S, Schott AM, Rizzoli R, Luckey M, FRAX Position Conference Members (2011) Official positions for FRAX clinical regarding international differences. J Clin Densitom 14:240–262
Chiavegatto Filho AD, Beltrán-Sánchez H, Kawachi I (2014) Racial disparities in life expectancy in Brazil: challenges from a multiracial society. Am J Public Health 104(11):2156–2162
Johansson H, Kanis JA, McCloskey EV, Odén A, Devogelaer J-P, Kaufman J-M, Neuprez A, Hiliigsmann M, Bruyere O, Reginster JY (2011) A FRAX® model for the assessment of fracture probability in Belgium. Osteoporos Int 22:453–461
Acknowledgements
This study was conceived by the late Sergio Ragi Eis, the memory to whom this paper is dedicated.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
HJ, NCH, EL, LV, ML, MS, EM and JAK are members of the FRAX team. EM and JAK are directors of Osteoporosis Research Ltd which develops and maintains FRAX. BHA, CAFZ, ML-C and TV declare no competing interests in relation to this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Albergaria, B.H., Zerbini, C.A.F., Lazaretti-Castro, M. et al. A new FRAX model for Brazil. Arch Osteoporos 18, 144 (2023). https://doi.org/10.1007/s11657-023-01354-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11657-023-01354-3